Analysts expect that Alteryx Inc (NYSE:AYX) will announce $76.45 million in sales for the current fiscal quarter, Zacks Investment Research reports. Seven analysts have made estimates for Alteryx’s earnings, with estimates ranging from $75.50 million to $78.80 million. Alteryx posted sales of $46.80 million during the same quarter last year, which would indicate a positive year-over-year growth rate of 63.4%. The business is expected to announce its next quarterly earnings results after the market closes on Wednesday, July 31st.
On average, analysts expect that Alteryx will report full-year sales of $359.95 million for the current financial year, with estimates ranging from $357.26 million to $370.40 million. For the next financial year, analysts anticipate that the company will post sales of $470.23 million, with estimates ranging from $453.79 million to $489.90 million. Zacks Investment Research’s sales averages are a mean average based on a survey of analysts that cover Alteryx.
Alteryx (NYSE:AYX) last posted its earnings results on Wednesday, May 1st. The company reported ($0.02) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.16) by $0.14. Alteryx had a negative net margin of 2.84% and a negative return on equity of 4.90%. The company had revenue of $76.02 million for the quarter, compared to analyst estimates of $71.41 million. During the same quarter in the prior year, the business posted ($0.01) EPS. The firm’s revenue was up 51.0% compared to the same quarter last year.
A number of research firms recently weighed in on AYX. Wedbush restated a “buy” rating on shares of Liquidia Technologies in a report on Thursday, May 2nd. Zacks Investment Research lowered shares of Haynes International from a “hold” rating to a “sell” rating in a research note on Wednesday, May 8th. JMP Securities increased their price objective on shares of Qualys from $85.00 to $100.00 and gave the company a “market outperform” rating in a research note on Thursday, May 2nd. Needham & Company LLC reiterated a “buy” rating and issued a $120.00 price objective (up previously from $108.00) on shares of Alteryx in a research note on Wednesday, June 12th. Finally, Goldman Sachs Group started coverage on shares of HubSpot in a research note on Friday, June 7th. They issued a “buy” rating and a $223.00 price objective for the company. Four research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average price target of $102.97.
In other news, insider Robert Scott Jones sold 1,599 shares of the stock in a transaction that occurred on Wednesday, June 5th. The shares were sold at an average price of $86.03, for a total transaction of $137,561.97. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Jeff Horing sold 37,148 shares of the stock in a transaction that occurred on Wednesday, June 12th. The shares were sold at an average price of $99.29, for a total transaction of $3,688,424.92. Following the transaction, the director now directly owns 6,081 shares of the company’s stock, valued at $603,782.49. The disclosure for this sale can be found here. In the last quarter, insiders sold 124,763 shares of company stock valued at $12,121,340. Company insiders own 19.82% of the company’s stock.
Institutional investors have recently added to or reduced their stakes in the company. Cooper Haims Advisors LLC bought a new position in shares of Alteryx during the 1st quarter valued at approximately $509,000. Assenagon Asset Management S.A. bought a new position in shares of Alteryx during the 1st quarter valued at approximately $4,976,000. Marshall Wace LLP bought a new position in shares of Alteryx during the 1st quarter valued at approximately $6,222,000. Legal & General Group Plc grew its position in shares of Alteryx by 3.4% during the 4th quarter. Legal & General Group Plc now owns 4,541 shares of the company’s stock valued at $270,000 after acquiring an additional 149 shares during the period. Finally, Hamilton Lane Advisors LLC grew its position in shares of Alteryx by 493.6% during the 1st quarter. Hamilton Lane Advisors LLC now owns 79,777 shares of the company’s stock valued at $6,691,000 after acquiring an additional 66,337 shares during the period. 64.24% of the stock is owned by hedge funds and other institutional investors.
Shares of AYX traded up $1.25 on Friday, reaching $117.25. The company’s stock had a trading volume of 811,294 shares, compared to its average volume of 1,126,775. The company has a quick ratio of 1.58, a current ratio of 1.58 and a debt-to-equity ratio of 0.07. Alteryx has a twelve month low of $38.58 and a twelve month high of $121.50. The firm has a market cap of $7.33 billion, a PE ratio of -586.25, a PEG ratio of 49.66 and a beta of 1.24. The company has a fifty day moving average of $106.06.
Alteryx Company Profile
Alteryx, Inc operates a self-service data analytics software platform that enables organizations to enhance business outcomes and the productivity of their business analysts, data scientists, and citizen data scientists worldwide. Its software platform includes Alteryx Designer, a data profiling, preparation, blending, and analytics product used to create visual workflows or analytic processes; Alteryx Server, a server-based product for scheduling, sharing, and running analytic processes and applications in a Web-based environment; Alteryx Connect, a collaborative data exploration platform for discovering information assets and sharing recommendations across the enterprise; and Alteryx Promote, an analytics model management product for data scientists and analytics teams to build, manage, monitor, and deploy predictive models into real-time production applications.
Featured Story: How Do You Calculate Return on Investment (ROI)?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Alteryx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alteryx and related companies with MarketBeat.com's FREE daily email newsletter.